# Colchicine in Vascular Inflammation Assessed With PET Imaging

> **NCT02162303** · PHASE2 · COMPLETED · sponsor: **Montreal Heart Institute** · enrollment: 106 (actual)

## Conditions studied

- Atherosclerotic Vascular Disease

## Interventions

- **DRUG:** Colchicine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02162303
- **Lead sponsor:** Montreal Heart Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-05
- **Primary completion:** 2015-07
- **Final completion:** 2016-01
- **Target enrollment:** 106 (ACTUAL)
- **Last updated:** 2020-02-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02162303

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02162303, "Colchicine in Vascular Inflammation Assessed With PET Imaging". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02162303. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*